Posts

Queen Bee Syndrome at Workplace – Asrar Qureshi’s Blog Post 1323

Image
Queen Bee Syndrome at Workplace – Asrar Qureshi’s Blog Post 1323 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1323 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Cedric Fauntleroy Preamble This blogpost is based on key insights from an INSEAD article by Henrike Gueth, Nicolas Bastoli, and Winnie Jiang. Link at the end. Queen Bee Syndrome: When Women Hold Other Women Back at Work There is an uncomfortable phenomenon in organizations. Some women who have successfully reached senior positions may become less supportive of other women trying to advance. They may be reluctant to mentor younger women, exclude them from influential networks, judge them more harshly, or become highly competitive with them. This behavior is commonly described as “Queen Bee Syndrome.” The term, however, can be misleading. It suggests ...
Post a Comment
Read more

Rethink Gender-based Marketing – Asrar Qureshi’s Blog Post #1322

Image
Rethink Gender-based Marketing – Asrar Qureshi’s Blog Post #1322 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1322 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Nothing Ahead Preamble Gaby Barrios’s TED Talk makes a deceptively simple argument: gender is often an easy marketing variable, but it is frequently a poor predictor of what people actually need or buy. Drawing on BCG work across more than 20 countries and roughly 100,000 “statistical tournaments,” she says gender emerged as the most useful variable for understanding consumer needs only about 5% of the time. Her broader recommendation is to move from demographic shortcuts toward needs, occasions, attitudes, behaviors and context. Stop Marketing to Men and Women. Start Marketing to Needs. What pharmaceutical marketers can learn from Gaby Barrios abo...
Post a Comment
Read more

The Great Divide in Pakistan Pharma Market – Suggestions for Smaller Companies – Asrar Qureshi’s Blog Post #1321

Image
The Great Divide in Pakistan Pharma Market – Suggestions for Smaller Companies – Asrar Qureshi’s Blog Post #1321 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1321 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Shvets Production Preamble As shown in the last blog post, there is a great divide in the pharma market of Pakistan. I continuation with the previous blog post, here are some suggestions how smaller companies can get a decent foothold in the market. The Great Divide in Pakistan Pharma: How Smaller Companies Can Build a Respectable Foothold Pakistan's pharmaceutical market has a great divide. On one side are the large companies with substantial market shares, extensive product portfolios, strong distribution networks, large sales forces and well-established brands.On the other side are hundreds of smal...
Post a Comment
Read more

Pakistan Pharma Market – Uneven Distribution and Its Impact on Competition and Strategy – Asrar Qureshi’s Blog Post #1320

Image
Pakistan Pharma Market – Uneven Distribution and Its Impact on Competition and Strategy – Asrar Qureshi’s Blog Post #1320 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1320 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Elements Interactive Preamble A highly concentrated market creates winners, survivors, and a strategic problem for everyone else Pakistan's pharmaceutical market presents a fascinating paradox. On one side is an industry with hundreds of pharmaceutical companies, a large manufacturing base and a growing domestic demand for medicines. On the other is a market in which a relatively small number of companies capture the overwhelming majority of sales. Industry data has consistently shown this concentration. A 2023 VIS sector report estimated that the top 50 companies held nearly 90% of the marke...
Post a Comment
Read more

Why Should Childhood Cancer Survival Depend on Where the Child is Born? – Asrar Qureshi’s Blog Post #1319

Image
Why Should Childhood Cancer Survival Depend on Where the Child is Born? – Asrar Qureshi’s Blog Post #1319 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1319 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Pavel Danilyuk Preamble This post is based on a World Health Organization Report.. Link at the end. WHO’s 2026 report, Measuring survival, driving change: advancing equity through the WHO Global Initiative for Childhood Cancer, examines one of the most striking inequalities in global health: children with cancer can face dramatically different chances of survival depending on where they live. The report introduces comparable five-year survival estimates for lymphoid leukaemia across 194 Member States and links better data to stronger policy and health-system action. WHO’s global target is at least 60% childh...
Post a Comment
Read more

Women are Living Longer, But are they Living healthier? – Asrar Qureshi’s Blog Post #1318

Image
Women are Living Longer, But are they Living healthier? – Asrar Qureshi’s Blog Post #1318 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1318 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Yan Krukau Credit: Mikhail Nilov Credit: Nguyen Tien Thinh Preamble This post is based on recently published Boston Consulting Group research. Link at the end. The $350 Billion Question: Why Women’s Longevity Is the Next Big Healthcare Opportunity Women are living longer, but are they living healthier? That question may become one of the most important questions in healthcare over the next decade. Women generally live longer than men. Yet the additional years are not necessarily years of good health. According to Boston Consulting Group’s latest research on women and longevity, women spend a larger proportion of their lives...
Post a Comment
Read more

Turning Organizational Values into Everyday Behavior – Asrar Qureshi’s Blog Post #1317

Image
Turning Organizational Values into Everyday Behavior – Asrar Qureshi’s Blog Post #1317 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1317 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Hassan Zaheer Preamble This post is based on Harvard Business Review article. Link at the end. From Values to Action: How Leaders Make Principles Hold Under Pressure Part 2 of 2 — Turning Organizational Values into Everyday Behavior What happens to organizational values when following them becomes difficult? The answer determines whether values are merely corporate language or an actual part of organizational culture. Values do not become real simply because leadership declares them. They become real when they are embedded into the organization's decisions, systems, incentives, leadership behavior and consequences. In other wo...
Post a Comment
Read more